<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/5936">
<title>Medical Laboratory Sciences</title>
<link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/5936</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/12950"/>
<rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11204"/>
<rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11200"/>
<rdf:li rdf:resource="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11199"/>
</rdf:Seq>
</items>
<dc:date>2026-09-18T23:54:08Z</dc:date>
</channel>
<item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/12950">
<title>Population-adjusted cut-off: A new approach for enhancing the diagnostic efficacy of hematological discrimination formulae for screening β-Thalassemia trait</title>
<link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/12950</link>
<description>Population-adjusted cut-off: A new approach for enhancing the diagnostic efficacy of hematological discrimination formulae for screening β-Thalassemia trait
Karunaithas, R.; Aravinda, I.; Dharmasiri, S.; Sewwandi, C.; Karunaithas, S.; Goonetilleke, S.
Screening for β-thalassemia trait (βTT) is crucial for preventing β-thalassemia major&#13;
in offspring. Although hematological discrimination formulae (HDF), developed using complete&#13;
blood count parameters, are cost-effective tools for screening βTT, their performance varies&#13;
across different populations. This study evaluated the performance of 32 HDF for screening βTT&#13;
in the Sri Lankan population. Data were retrieved from laboratory databases and categorized into&#13;
confirmed βTT and non-βTT groups based on high-performance liquid chromatography results.&#13;
The βTT screening performance of the HDF was assessed using accuracy measurements, the&#13;
receiver operating characteristic (ROC) curve, and Youden’s index (YI). Furthermore, a&#13;
population-adjusted cut-off was determined using the Index of Union (IU) method to optimize&#13;
the predictive accuracy of HDF in screening βTT. Bordbar demonstrated excellent predictive&#13;
performance in males (AUC = 0.908; YI = 0.815), while Shine &amp; Lal, Kerman-I, Nishad, Sehgal,&#13;
Bordbar, and Roth demonstrated high discriminative ability in females (AUC &gt; 0.833; YI &gt;&#13;
0.666). Applying a population-adjusted cut-off improved the βTT screening potential of Shine &amp;&#13;
Lal, Kerman-I, Nishad, Bordbar, and Roth in males (AUC &gt; 0.911; YI &gt; 0.822) and enhanced&#13;
the performance of Kerman-II in females (AUC &gt; 0.861; YI &gt; 0.722). Notably, Shine &amp; Lal&#13;
(AUC = 0.937; YI &gt; 0.873) and Nishad (AUC = 0.897; YI &gt; 0.794) demonstrated the best&#13;
performance for males and females, respectively, when a population-adjusted cut-off was applied&#13;
for screening βTT. In conclusion, determining a population-adjusted cut-off is a new initiative to&#13;
enhance the βTT screening performance of HDF across different populations.
</description>
<dc:date>2026-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11204">
<title>Exploring urinary biomarkers for the diagnosis of diabetic and hypertensive  chronic kidney disease: A promising pilot study</title>
<link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11204</link>
<description>Exploring urinary biomarkers for the diagnosis of diabetic and hypertensive  chronic kidney disease: A promising pilot study
Saseevan, S.; Nishanthi, N.; Sanath, R.; Magana-Arachchi, D.
In the current clinical setting, conventional serum biomarkers such as serum creatinine (Scr) and estimated glomerular&#13;
filtration rate (eGFR) have several lapses in chronic kidney disease (CKD) diagnosis. Diagnosing CKD using non-invasive&#13;
methods is crucial for implementing prompt therapeutic interventions and preventing disease progression. This study aims to&#13;
identify the potential diagnostic urinary biomarkers and their correlation with existing renal markers, Scr, eGFR, and&#13;
proteinuria in diabetic and hypertensive CKD. RNA was extracted from eighty-two urine samples of CKD patients and&#13;
healthy controls (HC) and reverse transcribed for gene expression analysis using quantitative polymerase chain reactions.&#13;
The expression of NGAL, MMP9, ANXA3, OLFM4, PI3, and PRMT3 genes was analyzed relative to the reference gene,&#13;
B2M. Fold changes (FC) in gene expression in diabetic nephropathy (DN), and hypertensive nephropathy (HT) were&#13;
calculated against HC. Log2 normalized FC was used to determine significance levels and correlation with existing serum&#13;
markers. NGAL, ANXA3, and OLFM4 exhibited the highest upregulations in DN with mean Log2FC 1.42, 2.66, and 5.87,&#13;
respectively. A two-fold increase in NGAL FC was observed in early DN than in late DN, suggesting its potential as an early&#13;
urinary biomarker for DN. PI3 and MMP9 were upregulated in HT patients with higher FC values. PRMT3 showed a&#13;
significant negative correlation (P&lt;0.05) in HT patients with Scr (r=−0.738) and proteinuria (r=−0.906). The gene panels&#13;
including ANXA3, OLFM4, and NGAL, and PI3, PRMT3, and MMP9, could have potential diagnostic value in DN and HT,&#13;
respectively.
</description>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11200">
<title>RNA extraction from urine sediment: A cost-effective protocol for gene expression analysis in renal pathology.</title>
<link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11200</link>
<description>RNA extraction from urine sediment: A cost-effective protocol for gene expression analysis in renal pathology.
Saseevan, S.; Rajapakse, S.; Magana-Arachchi, D.N.
Urine is an appropriate choice of specimen to study&#13;
the biomarkers for metabolic and renal disorders because it is&#13;
readily available with less harm to the patients. However, RNA&#13;
extraction from voided urine is challenging due to the presence of&#13;
RNases and cell scarcity. This study aims to optimize a protocol&#13;
for RNA extraction from urine samples for gene expression&#13;
studies in renal pathology. Hundred and two urine samples&#13;
were collected from both healthy controls (HC) (&#119899; = 15; 54 ±&#13;
11 years) and chronic kidney disease (CKD) patients (&#119899; = 87;&#13;
56 ± 10 years) and centrifuged at 6,500 ɡ for 20 min at 4 °C to&#13;
obtain sediment. RNA was extracted from urine sediments using&#13;
a phenol-based technique. The extracted RNA was quantified and&#13;
reverse-transcribed into complementary DNA (cDNA). Reverse&#13;
transcriptase quantitative polymerase chain reactions (RT- qPCR)&#13;
were carried out using 2 ng of template cDNA to amplify the&#13;
housekeeping gene, β2- microglobulin (B2M). The total yield of&#13;
RNA from CKD and HC samples were 718 ± 164 ng and 790 ±&#13;
231 ng, respectively, and a statistically significant difference was&#13;
not observed between the two study groups (p &gt; 0.05). The urinary&#13;
RNA recovery was significantly increased with CKD progression&#13;
(p &lt; 0.05). Further, the results show that urine volume, gender,&#13;
and serum creatinine level significantly influence the RNA yield&#13;
in only disease groups (p &lt; 0.05). The mean threshold cycle (Ct)&#13;
values for B2M amplification of CKD and HC were 27.36 ± 3.09&#13;
and 20.97 ± 3.90, respectively. This modified phenol-chloroformbased&#13;
urinary RNA extraction method is less expensive and does&#13;
not require pre- and post-purification steps. It provides a higher&#13;
yield of RNA with less inhibition to qPCR and is sufficient for&#13;
downstream applications than column-based techniques.
</description>
<dc:date>2020-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11199">
<title>Culturable bacterial pathogens in midstream urine of chronic kidney disease patients in Vavuniya, Sri Lanka: A preliminary study</title>
<link>http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11199</link>
<description>Culturable bacterial pathogens in midstream urine of chronic kidney disease patients in Vavuniya, Sri Lanka: A preliminary study
Jayalath, J.M.S.D.; Saseevan, S.; Perera, W.A.K.; Magana-Arachchi, D.N.
Background: Contribution of the midstream urine microbiome to chronic kidney disease (CKD) is clinically relevant, yet it’s understudied.&#13;
Objectives: To identify bacteria from midstream urine of CKD patients with comorbidities of diabetes mellitus (DM), hypertension (HT) and other causes, in Vavuniya.&#13;
Methods: A total of seventeen (n = 17) midstream clean-catch urine samples were collected from CKD patients (56.59 ± 12.91 years) at the District General Hospital, Vavuniya, belonging to CKD + HT (n = 8), CKD + DM (n = 2), CKD + HT + DM (n = 3) and causes of CKD other than DM and HT (n = 4). Non-CKD healthy controls (n = 8; 56 ± 11 years) were included for comparison. Samples were transported on ice and immediately refrigerated at 4°C until processed. 10μl per sample was inoculated onto Luria-Bertani (LB) agar plates in duplicates and incubated aerobically at 37°C for 24 hours. Morphologically different bacterial colonies were subcultured in LB broth to obtain pure isolates, which underwent gram staining, and biochemical analyses for preliminary identification.&#13;
Results: Mean colony count for CKD subjects was 2,500 ± 967 CFU/mL and 286 ± 181 CFU/mL for controls. The CKD + HT + DM group had the highest mean colony count. In total, 24 bacterial isolates were obtained from the patients’ urine of which 45.8% were gram positive cocci, 37.5% were gram negative rods and bacterial genera Staphylococcus (33%), Streptococcus (12.5%), Pseudomonas (4%), Klebsiella (4%) and Proteus (4%) were identified. Staphylococcus, Corynebacteria, Proteus, Escherichia, and Citrobacter were found in controls.&#13;
Conclusion: Various viable uropathogens in the midstream urine of CKD patients were identified using culture-based tests. This preliminary study is currently ongoing to further identify the midstream urine microbiome in CKD with molecular techniques too, as culture alone is insufficient.
</description>
<dc:date>2021-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
